Palisade Bio Inc [NASDAQ: PALI] gained 41.86% on the last trading session, reaching $1.22 price per share at the time.
Palisade Bio Inc represents 4.80 million in outstanding shares, while the company has a total market value of $5.84 million with the latest information. PALI stock price has been found in the range of $0.855 to $1.36.
If compared to the average trading volume of 337.67K shares, PALI reached a trading volume of 11865834 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Palisade Bio Inc [PALI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PALI shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PALI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 1.01, with the Price to Cash per share for the same quarter was set at 1.51.
Trading performance analysis for PALI stock
Palisade Bio Inc [PALI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 62.45. With this latest performance, PALI shares gained by 73.94% in over the last four-week period, additionally sinking by -19.21% over the last 6 months – not to mention a drop of -26.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PALI stock in for the last two-week period is set at 78.38, with the RSI for the last a single of trading hit 0.1170, and the three-weeks RSI is set at 0.0834 for Palisade Bio Inc [PALI]. The present Moving Average for the last 50 days of trading for this stock 0.7352, while it was recorded at 0.9047 for the last single week of trading, and 1.4480 for the last 200 days.
Palisade Bio Inc (PALI) Capital Structure & Debt Analysis
According to recent financial data for Palisade Bio Inc. ( PALI), the Return on Equity (ROE) stands at -170.72%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -126.10%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Palisade Bio Inc’s Return on Invested Capital (ROIC) is -246.50%, showcasing its effectiveness in deploying capital for earnings.
Palisade Bio Inc (PALI) Efficiency & Liquidity Metrics
Based on Palisade Bio Inc’s (PALI) latest financial statements, the Debt-to-Equity Ratio is 0.01%, indicating its reliance on debt financing relative to shareholder equity.
Palisade Bio Inc (PALI) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Palisade Bio Inc. (PALI) effectively leverages its workforce, generating an average of -$1642500.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.81% and a Quick Ratio of 2.81%, indicating strong ability to cover short-term liabilities.
Palisade Bio Inc [PALI]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PALI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Palisade Bio Inc go to 55.06%.
An analysis of Institutional ownership at Palisade Bio Inc [PALI]
There are presently around $5.43%, or 5.46% of PALI stock, in the hands of institutional investors.
